Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Market Veteran Crowther Lobbies For Nutritional Product Regs

This article was originally published in The Tan Sheet

Executive Summary

The U.S.-China Health Products Association is pushing China's regulators to publish health food regulations to help spur Western firms' entry into the country.

You may also be interested in...



Product Registration Regime Chokes China Supplement Industry Growth

The U.S.-China Health Products Association says China is considering reforms to the country’s food product industry regulations. Relaxing the supplement registration requirement would increase demand for Chinese suppliers’ ingredients from firms that would sell more of their finished products in the country.

Product Registration Regime Chokes China Supplement Industry Growth

The U.S.-China Health Products Association says China is considering reforms to the country’s food product industry regulations. Relaxing the supplement registration requirement would increase demand for Chinese suppliers’ ingredients from firms that would sell more of their finished products in the country.

GNC Advances Ambitious China Retail Plans With Shanghai Store

The dietary supplement retailer opened its first standalone Chinese location July 23, with plans for another 25 locations in China over the coming 12 months. Analysts see the country as offering a “significant white space opportunity” for nutritional product retail sales.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS104929

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel